Preview

Siberian Journal of Clinical and Experimental Medicine

Advanced search

CONCOMITANT PROCEDURE OF ATRIAL FIBRILLATION ABLATION WITH AND WITHOUT LEFT ATRIOPLASTY DURING SURGICAL CORRECTION OF THE MITRAL VALVE DISEASE: PROSPECTIVE, RANDOMIZED TRIAL

https://doi.org/10.29001/2073-8552-2018-33-3-63-70

Abstract

Objective. Main objective of this prospective randomized study was to assess safety and efficiency of the combined approach for the left atrial ablation in combination with and without reduction left atrioplasty in patients with mitral valve disease.

Material and Methods. The study was performed from September, 2014 to February, 2017. A total of 120 patients with mitral valve disease, permanent atrial fibrillation (AF), and left atriomegaly were enrolled in the study. Patients were randomized to two groups: group I comprised patients who received correction of mitral valve disease in combination with AF ablation and without reduction atrioplasty of the left atrium (MV+MAZE); group II (n=60) comprised patients with correction of mitral valve disease in combination with AF ablation and with reduction atrioplasty of the left atrium (MV+MAZE+AP). Patient characteristics did not differ between groups.
Results. There were no significant differences between groups in the early mortality rates (2 patients in group I versus 5 patients in group II, p=0.64); bleeding rates (total 5 cases including 2 patients in group I and 3 patients in group II, p=0.34), and the rates of AF recurrence in the early postoperative period. Permanent pacemakers were implanted in 8 patients (13.3%) of group I and in 4 patients (6.7%) of group II. Total long-term mortality was 4 patients including 1 and 3 patients in group I and II, respectively, which did not significantly differed. The rates of one-year freedom from AF were 84.8 and 86.2% in group I and II, respectively. No new onsets of atrial fibrillation were observed for 36 months in both groups. The rates of freedom from thromboembolic events during the time of observation were 88.6% in group I and 96.5% in group II. 

Conclusion. The left atrial reduction concomitant with the left atrial ablation and correction of mitral valve disease is safe and effective procedure. However, this procedure did not impact the rates of long-term freedom from AF.

About the Authors

A. V. Bogachev-Prokophiev
Meshalkin National Medical Research Center
Russian Federation

Dr. Sci. (Med.), Head of New Surgical Technologies Center

15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation



S. I. Zheleznev
Meshalkin National Medical Research Center
Russian Federation

Dr. Sci. (Med.), Professor, Cardiovascular Surgeon at Valvular Heart Disease Surgery Department

15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation



M. A. Ovcharov
Meshalkin National Medical Research Center
Russian Federation

Researcher at New Surgical Technologies Center

15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation



A. V. Afanasyev
Meshalkin National Medical Research Center
Russian Federation

Cand. Sci. (Med.), Cardiovascular Surgeon at Valvular Heart Disease Surgery Department

15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation



R. M. Sharifulin
Meshalkin National Medical Research Center
Russian Federation

Cand. Sci. (Med.), Cardiovascular Surgeon at Valvular Heart Disease Surgery Department

15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation



S. O. Lavinukov
Meshalkin National Medical Research Center
Russian Federation

Cand. Sci. (Med.), Cardiovascular Surgeon at Valvular Heart Disease Surgery Department

15, Rechkunovskaya str., Novosibirsk, 630055, Russian Federation



References

1. Gillinow A., Salman A. Ablation of atrial fibrillation with concomitant cardiac surgery. Thorac. Cardiovasc. Surg. 2007; 19: 25–32.

2. Cox J. L., Churyla A., Malaisrie S. C., Kruse J., Pham D. T., Kislitsina O. N., McCarthy P. M. When is a Maze Procedure a Maze Procedure? Can. J. Cardiology. 2018. DOI: 10.1016/j.cjca.2018.05.008. Reference: CJCA 2827. Accepted Date: 7 May 2018.

3. Benussi S., Pappone C., Nascimbene S., Oreto G., Caldarola A., Stefano P. L., Casati V., Alfieri O. A simple way to treat chronic atrial fibrillation during mitrale valve surgery: the epicardial radiofrequency approach. Eur. J. Cardiothorac. Surg. 2000; 17: 524–529.

4. Di Eusanio G., Gregorini R., Mazzola A., Clementi G., Procaccini B., Cavarra F., Taraschi F., Esposito G., Di Nardo W., Di Luzio V. Giant left atrium and mitral valve replacement: risk factor analysis. Eur. J. Cardiothorac. Surg. 1988; 2: 151–159.

5. Bando K., Kasegawa H., Okada Y., Kobayashi J., Kada A., Shimokawa T., Nasu M., Nakatani S., Niwaya K., Tagusari O., Nakajima H., Hirata M., Yagihara T., Kitamura S. Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation. J. Thorac. Cardiovasc. Surg. 2005; 129(5): 1032–1040.

6. Kawazoe K., Beppu S., Takahara Y., Nakajima N., Tanaka K., Ichihashi K., Fujita T., Manabe H. Surgical treatment of giant left atrium combined with mitral valvular disease. Plication procedure for reduction of compression to the left ventricle, bronchus and pulmonary parenchyma. J. Thorac. Cardiovasc. Surg. 1983; 85(6): 885–892.

7. Apostolakis E., Shunaiber J. The surgical management of giant left atrium. Eur. J. Cardiothorac. Surg. 2008 February; 33(2): 182–190. DOI: 10.1016/j.ejcts.2007.11.003.

8. Wanga W., Guod L., Martlanda A. M., Fengb X., Mab J., Fengc X. Biatrial reduction plasty with reef imbricate technique as an adjunct to maze procedure for permanent atrial fibrillation associated with giant left atrial. Interact. Cardiovasc. Thorac. Surg. 010; 10: 577–581.

9. Kharqi K., Hutten B. A., Lemke B., Deneke T. Surgical treatment of atrial fibrillation: a systematic review. Eur. J. Cardiothorac. Surg. 2005; 27: 258–265.

10. Candan O., Ozdemir N., Aung S. M., Hatipoglu S., Karabay C. Y., Guler A., Gecmen C., Dogan C. Atrial longitudinal strain parameters predict left atrial reverse remodeling after mitral valve surgery: a speckle tracking echocardiography study. Int. J. Cardiovasc. Imaging. 2014; 30: 1049–1056. DOI: 10.1007/s10554-014-0433-9.

11. Scherer M. Left atrial size reduction improves the sinus rhythm conversion rate after radiofrequency ablation for continuous atrial fibrillation in patients undergoing concomitant cardiac surgery. Thorac. Cardiovasc. Surg. 2006; 54: 34–38.

12. Chen M. C., Chang J. P., Chang H. W. Preoperative atrial size predicts the success of radiofrequency maze procedure for permanent atrial fibrillation in patients undergoing concomitant valvular surgery. Chest. 2004 Jun; 125(6): 2129–2134.

13. Kasemsarn Ch., Lerdsomboon P., Sungkahaphong V., Chotivatanapong T. Left atrial reduction in modified maze procedure with concomitant mitral surgery. Asian Cardiovascular & Thoracic Annals. 2014; 22(4): 421–429. Author(s) 2013. Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/0218492313492438.

14. Hyllen S., Nozohoor Sh., Meurling C., Wierup P., Sjögren J. Left Atrial Reverse Remodeling Following Valve Surgery for Chronic Degenerative Mitral Regurgitation in Patients with Preoperative Sinus Rhythm: Effects on Long-Term Outcome. J. Card. Surg. 2013; 28: 619–626. DOI: 10.1111/jocs.12215.

15. Evtushenko A. V., Evtushenko V. V., Belenkova E. M., Antonchenko I. V. Definition of the concept of increasing the effectiveness of the long-term results of radiofrequency atrial ablation by the «maze» procedure based on the experience of two hundred operations. Vestnik Arithmologii. 2012; 69: 5–11 (In Russ).


Review

For citations:


Bogachev-Prokophiev A.V., Zheleznev S.I., Ovcharov M.A., Afanasyev A.V., Sharifulin R.M., Lavinukov S.O. CONCOMITANT PROCEDURE OF ATRIAL FIBRILLATION ABLATION WITH AND WITHOUT LEFT ATRIOPLASTY DURING SURGICAL CORRECTION OF THE MITRAL VALVE DISEASE: PROSPECTIVE, RANDOMIZED TRIAL. Siberian Journal of Clinical and Experimental Medicine. 2018;33(3):63-70. (In Russ.) https://doi.org/10.29001/2073-8552-2018-33-3-63-70

Views: 564


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2713-2927 (Print)
ISSN 2713-265X (Online)